MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurostimulation"

  • 2018 International Congress

    Safety and efficacy of high definition tDCS for proprioception and balance in Parkinson’s disease: A pilot randomised trial

    H. Teasdale, E. Preston, A. Flood, G. Waddington (Canberra, Australia)

    Objective: To determine: 1. Is HD-tDCS safe and well-tolerated in PD? 2. Does combined HD-tDCS and physical exercise improve proprioception and balance in PD? Background:…
  • 2018 International Congress

    Outcomes of a Prospective, Multi-center International Registry of Deep Brain Stimulation for Parkinson’s Disease

    G. Deuschl, R. Jain, H. Scholtes, A. Wang, M. Barbe, S. Paschen, A. Andrea Kühn, M. Pötter-Nerger, J. Volkmann, J. Vesper (Kiel, Germany)

    Objective: The objective this report is to describe collected outcomes from a large scale registry of a Deep Brain Stimulation (DBS) system capable of Multiple…
  • 2018 International Congress

    Tremor suppression by phase-specific transcranial alternating current stimulation in dystonia and essential tremor

    F. Nieuwhof, E. Klimars, I. Toni, B. vande Warrenburg, R. Helmich (Nijmegen, Netherlands)

    Objective: Investigate whether frequency- and phase-specific transcranial alternating current stimulation (TACS) over the primary motor cortex and cerebellum influences tremor in dystonia and essential tremor.…
  • 2017 International Congress

    Safety of Unilateral and Bilateral DBS implants in ET: Preliminary results from Product Surveillance Registry

    M. Schiess, S. Falowski, G. Plotkin, S. Palfi, T. Witt, E. Cuny, T. Theys, K. Martinez, R. Plunkett, Y. Temel, G. Johnson, T. Weaver, J. Krauss, P. Konrad (Houston, TX, USA)

    Objective: To compare the safety of unilateral  (Uni) to bilateral (Blt) DBS implants in Essential Tremor (ET).  Background: DBS is an effective therapy in reducing…
  • 2017 International Congress

    Pharmaeconomic study of the treatment of advanced Parkinson’s disease.

    F. VIVANCOS-MATELLANO, A. SANZ, J.U. MIRÓ, J. CADAVID, A. RUÍZ, N. SOLER (Madrid, Spain)

    Objective: Conduct a comparative pharmacoeconomic analysis of the use of  subcutaneous apomorphine infusion pump (SAIP),   continuous levodopa/carbidopa duodenal infusión (LDI) and deep brain stimulation (DBS). Background:…
  • 2017 International Congress

    Safe Functional MR Imaging in STN-DBS implanted Parkinson’s disease

    M. Saxena, C. McIntyre, B. Walter (Cleveland, OH, USA)

    Objective: Evaluation of clinically optimized settings in bilateral STN-DBS Parkinson’s disease, allows anatomical correlations with benefits and side effects. Background: MRI acquisition can cause permanent…
  • 2017 International Congress

    Efficacy and tolerability of low-frequency deep brain stimulation during daytime only in Parkinson’s disease: a pilot study

    F. Dematteis, M. Zibetti, E. Montanaro, L. Rizzi, M. Lanotte, L. Lopiano, M. Rizzone (Torino, Italy)

    Objective: To compare the efficacy and tolerability of low-frequency stimulation (LFS) during daytime only to LFS applied 24 hours a day, in PD patients bilaterally…
  • 2017 International Congress

    Somnolence as untoward stimulation effect in subthalamic deep brain stimulation (STN DBS) for Parkinson’s disease (PD)

    F. Danisi, C. Miller (Poughkeepsie, NY, USA)

    Objective: Excessive daytime sleepiness is a relatively common feature in PD. However, it has not been reported as a side effect of STN DBS. We…
  • 2017 International Congress

    Deep Brain Stimulation (DBS) battery longevity of Medtronic Activa SC is briefer than preceding Soletra models, a within subject analysis

    E. Hargreaves, R. Patel, R. DiPaola, S. Wong, D. Caputo, S. Danish (New Brunswick, NJ, USA)

    Objective: To contrast the durations of Activa SCs with the durations of preceding Soletra neurostimulator models within the same individuals programmed at near constant parameters.…
  • 2017 International Congress

    Assessment of new technology in deep brain stimulation technology: what are the anticipated benefits?

    C. Butson (Salt Lake City, UT, USA)

    Objective: To assess the ability of directional DBS leads and stimulation field shaping to provide more precisely targeted therapy. Background: Deep brain stimulation (DBS) has…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley